Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioMarin Blows Past Q1 Estimates, Projects 1st Year of Profitability in 2020


Investors looking for something of a safe haven in the COVID-19 storm might like BioMarin Pharmaceutical (NASDAQ: BMRN). While most stocks have languished in 2020, the biotech's shares are up 12% so far this year.

BioMarin could pick up even more momentum now. The company announced its first-quarter results after the market closed on Wednesday. Here are the highlights from BioMarin's Q1 update.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments